Table 5.
Effects of CB2 agonists on immune cell functions
Cell type | Species | Agonist | Effects | References |
---|---|---|---|---|
Astrocytes | Human | WIN 55,212-2 |
↓ Nitric oxide ↓ TNF-α, IL-10, MCP-1 and CCL5 |
[126] |
Dendritic cells | Mouse | ∆9-THC | ↑ NF-κB-dependent apoptosis | [127] |
GP1a |
↓ MMP-9 ↓ Migration |
[128] | ||
Monocytes | Human | JWH-015 | ↓ CCL2 and CCL3-induced migration | [78] |
HU-308 JWH-133 |
↓ TNF-α-induced transendothelial migration | [129] | ||
Macrophages | Human (monocyte-derived) | JWH-133 | ↓ Expression of 35 genes upregulated by LPS | [130] |
JWH-133 GP1a O-1966 |
↓ HIV-1 replication | [75] | ||
Mouse (RAW264.7) | WIN 55,212-2 | ↓ Reactive oxygen species | [131] | |
↓ Nitric oxide | [132] | |||
Mouse (peritoneal) | ∆9-THC | ↓ RANTES-induced migration | [133] | |
JWH-133 |
↑ IL-10 ↓ IL-12p40 |
[134] | ||
Mouse (clone 63) | ∆9-THC | ↓ Activation of CD4+ T cells | [59] | |
Mast cells |
Rat (RBL-2H3) |
WIN 55,212-2 CP 55,940 |
↓ β-Hexosaminidase release | [135] |
Microglia | Human | WIN 55,212-2 | ↓ HIV-1 expression | [125] |
Rat | JWH-015 |
↓ LPS-induced TNF-α production ↓ Migration |
[136] | |
Neutrophils | Mouse | JWH-133 | ↓ MIP-2α-induced migration | [137] |
Human | JWH-133 | ↓ TNF-α-induced MMP-9 release | [138] | |
Splenocytes | Human | ∆9-THC | ↓ Primary and secondary antibody formation | [109] |
T cells | Human | ∆9-THC | ↓ Th2 cytokine production | [139] |
Human (Jurkat) |
CP 55,940 WIN 55,212-2 JWH-015 |
↓ SDF-1-induced migration | [140] | |
Mouse | O-1966 |
↓ NF-κB activation ↑ SOCS5 expression ↑ IL-10 |
[141] | |
CD8+ T cells | Human | JWH-015 | ↓ SDF-1-induced migration | [140] |
CCL chemokine (C–C motif) ligand, NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells, MMP matrix metallopeptidase, MIP macrophage inflammatory protein, HIV human immunodeficiency virus, SOCS suppressor of cytokine signaling